Max Robotics — Global Service Robot Directory + US Certification

About

William E. Gooding is a leading surgical oncologist whose research focuses on advancing minimally-invasive techniques for head and neck and pancreatic cancers, with a particular emphasis on robotic surgery and human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC). His landmark work includes a multicenter study on robotic reconstruction during the early learning curve for minimally-invasive pancreaticoduodenectomy (69 citations), which has guided safe adoption of complex robotic procedures. Gooding has also been instrumental in defining surgical learning curves for transoral robotic surgery (TORS) in OPSCC (50 citations), providing critical benchmarks for clinical trials and training. His investigations into oncologic outcomes for surgically treated early-stage OPSCC (27 citations) have helped refine treatment paradigms, while his more recent work demonstrating that PET/CT poorly predicts AJCC 8th edition pathologic staging in HPV-related OPSCC (14 citations) challenges conventional imaging-based staging approaches. Collectively, his research has accumulated over 160 citations, shaping best practices in robotic surgical training and the management of HPV-positive oropharyngeal cancers. Gooding’s contributions bridge the gap between surgical innovation and evidence-based oncology, making him a key figure in modern head and neck and pancreatic cancer surgery.